| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.8M | +27.6% | +54.2% |
| R&D Expense | $11.1M | +32.7% | +37.5% |
| SG&A Expense | $8.2M | +21.6% | +31.0% |
| Operating Income | -$17.6M | -27.8% | -33.0% |
| Interest Expense | $1.3M | +8.3% | — |
| Net Income | -$20.1M | -36.0% | -54.6% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $37.6M | +14.5% | -7.5% |
| Total Assets | $57.6M | +7.5% | -7.0% |
| Current Liabilities | $20.4M | +13.2% | +29.2% |
| Long-term Debt | $28.4M | +1.3% | +1707.8% |
| Total Liabilities | $54.1M | +7.0% | +153.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$43.0M | — | — |
| Capital Expenditures | $150K | — | — |
| Investing Cash Flow | -$276K | — | — |
| Financing Cash Flow | $17.3M | — | — |
| Free Cash Flow | -$43.2M | — | — |
| $3.5M |
| +15.8% |
| -91.3% |